Rel-methyl (3R,6R)-6-methylpiperidine-3-carboxylate hydrochloride

Catalog No. :
ACHSVL954
CAS No. :
1009376-86-6
Molecular Formula :
C8H16ClNO2
Molecular Weight :
193.67

IUPAC Name:methyl (3R,6R)-6-methylpiperidine-3-carboxylate hydrochloride

Rel-methyl (3R,6R)-6-methylpiperidine-3-carboxylate hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$65.00Login to see priceIn stockInquiry
1g95%$168.00Login to see priceIn stockInquiry
5g95%$588.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameRel-methyl (3R,6R)-6-methylpiperidine-3-carboxylate hydrochloride
IUPAC Namemethyl (3R,6R)-6-methylpiperidine-3-carboxylate hydrochloride
MDL No.MFCD27997461
Molecular FormulaC8H16ClNO2
Molecular Weight193.67
SMILESO=C([C@H]1CN[C@H](C)CC1)OC.[H]Cl
InChI KeyCOCIOCKRYRXGEP-ZJLYAJKPSA-N
Synonym1009376-86-6 | trans-Methyl 6-methylpiperidine-3-carboxylate hydrochloride | trans-Methyl 6-methylpiperidine-3-carboxylate HCl | Methyl trans-6-Methylpiperidine-3-carboxylate Hydrochloride | 1009377-11-0 | 3-Piperidinecarboxylic acid, 6-methyl-, methyl ester, hydro
CAS No.1009376-86-6
PubChem CID68586935

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACHSVL954 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCJGK834 route compound structure diagram
    ACCJGK8345470-70-2 In Stock
  2. Then
  3. ACHSVL954 route product structure diagram
    ACHSVL9541009376-86-6 In Stock
Inquiry

2. ACHSVL954 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHSVL954 route product structure diagram
    ACHSVL9541009376-86-6 In Stock
Inquiry

Comments (0)